Table 3.
Plasma HIV RNA > 75 copies/mL plus Transmission Risk Behavior on ART*
| VL <75 and/or low risk |
VL >75 + high risk |
P-value | MV OR (95% CI) |
P-value | |
|---|---|---|---|---|---|
| Total | 125 (90%) | 14 (10%) | -- | -- | -- |
| Age (IQR) | 46 (39–51) | 44 (38–50) | 0.704 | -- | -- |
| Black Race | 36 (30%) | 12 (71%) | 0.002 | 8.00 (1.83–34.92) | 0.006 |
| Hispanic Ethnicity | 37 (33%) | 4 (24%) | 0.579 | -- | -- |
| Education ≤ HS diploma | 30 (25%) | 6 (33%) | 0.564 | -- | -- |
|
Household Income <2000 >=2000 |
67 (74%) 23 (26%) |
13 (93%) 1 (7%) |
0.18 | -- | -- |
| CD4 count | 604 (435–755) | 305 (150–501) | 0.002 | 0.657 (0.479–0.902) | 0.009 |
| Months on ART (IQR) | 36 (15–63) | 29 (13–45) | 0.314 | -- | -- |
| # of meds (IQR) | 4 (3–6) | 5 (3–6) | 0.143 | 1.76 (0.54–5.78) | 0.353 |
| PI-based regimen | 65 (54%) | 14 (78%) | 0.074 | 0.36 (0.7=22–5.88) | 0.471 |
|
Last time missed med > 3m ago Within last 3m |
56 (46%) 65 (54%) |
2 (11%) 16 (89%) |
0.004 |
5.10 (0.73–35.69) |
0.100 |
| Self-reported ARV status <90% adherent | 13 (11%) | 5 (28%) | 0.067 | -- | -- |
| STI in past 30 days | 9 (8%) | 4 (22%) | 0.07 | 5.25 (.74–37.43) | 0.098 |
| Psychiatric Dx | 67 (55%) | 11 (61%) | 0.8 | -- | -- |
| Depression Score | 19 (13–24) | 23 (18–31) | 0.036 | 1.01 (0.93–1.09) | 0.811 |
| Drug use in past 30d | 42 (35%) | 9 (50%) | 0.296 | -- | -- |
| Meth use in past 30d | 13 (11%) | 7 (39%) | 0.006 | 5.20 (1.06–10.23) | 0.042 |
| IVDU in past 30 days | 3 (3%) | 2 (11%) | 0.128 | -- | -- |
| Regular HIV+ partner | 47 (40%) | 13 (72%) | 0.011 | 2.48 (.060–10.23) | 0.208 |
| Regular HIV- or unknown partner | 55 (46%) | 6 (33%) | 0.446 | -- | -- |
| Casual HIV+ sex partner | 25 (21%) | 7 (39%) | 0.132 | 0.49 (0.096–2.44) | 0.380 |
| Casual HIV- or unknown partner | 31 (26%) | 9 (50%) | 0.051 | 2.52 (0.61–10.46) | 0.204 |
*
All categorical assessments are depicted as n (%) and continuous variables as median (Interquartile Range)